Biotech · Private company
Acepodia Biotech, Inc.
Track this companyFree. Adds Acepodia Biotech, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- ACE1831Phase 2 · IgG4 Related DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Lymphodepleting chemotherapyPhase 2 · IgG4 Related DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ACE1702Phase 1 · Locally Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ACE1831Phase 1 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- ACE2016Phase 1 · Locally Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · Locally Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 1 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · Locally Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- FludarabinePhase 1 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- ObinutuzumabPhase 1 · B-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · Locally Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related DiseasePHASE1_PHASE2 · RECRUITING · started Jan 1, 2026ClinicalTrials.gov NCT07061938 · fetched Nov 12, 2026
- ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)PHASE1 · RECRUITING · started Aug 22, 2024ClinicalTrials.gov NCT06415487 · fetched Nov 12, 2026
- ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell MalignanciesPHASE1 · COMPLETED · started Jan 21, 2023ClinicalTrials.gov NCT05653271 · fetched Nov 12, 2026
- ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid TumorsPHASE1 · COMPLETED · started Jun 24, 2020ClinicalTrials.gov NCT04319757 · fetched Nov 12, 2026